High performance computing is stimulating collaborative research across state - and country - borders.

Alan Harvey will discuss neurotrauma research, Cliff Richard and the role of music in the evolution of the modern mind at the ANS meeting this week.

Point-of-care testing is an emerging field within community medicine and will be discussed at this week's South Pacific Congress in Auckland.

Privately-held vaccine developer Vaxine and Flinders University have been awarded a grant of US$2.5 million over three years by the US National Institutes of Health (NIH) to develop vaccines that protect against bioterrorist attacks.

The South Australian branch of the AusBiotech Student Association (ABSA) was launched last night in Adelaide.

Adelaide drug-discovery company Bionomics (ASX:BNO, US OTC:BMICY) has appointed Dr Tim Harris, CEO and co-founder of US biotech Structural GenomiX, to its advisory board.

Members of South Australia's BioAngels have made their first investment into the South Australian bioscience sector, selecting Australian Orthopaedic Innovations from more than 20 applications.

A new South Australian initiative aims to give scientists in that state easier access to expensive research equipment and expertise.

Bioactive compound development company Novogen (ASX:NRT) has appointed the chief of biotech TGR BioSsciences to its board of directors.

Melbourne drug discovery company BioDiem has appointed two new executives as it gears up for a public listing.

A $1.5 million Biotechnology Fellowship Fund, launched last week by the South Australian government agency Bio Innovation SA, will bring three internationally renowned scientists to South Australia's universities.